No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?
Shareholders in Bio-Rad Laboratories (NYSE:BIO) Are in the Red If They Invested Three Years Ago
What You Need to Know Ahead of Bio-Rad Laboratories' Earnings Release
Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
Express News | NYSE Halt Bio-Rad Labs B Add Info Lst $283.450400
Incyte, Moderna Among Most Shorted S&P 500 Healthcare Stocks in June